Cohnreznick Advisory LLC

Parsippany, NJ Professional servicesNAICS 541211

Self-funded health planPlan year 2025Renews January
3,808ParticipantsFirst year on file
$9.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#5 of 32Professional services in NJBy participants

Overview

Cohnreznick Advisory LLC sponsors a self-funded health plan that covered 3,808 participants in plan year 2025. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, prepaid legal, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
3,808
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Cohnreznick Advisors, LLC Employee Benefits Program for Active Employees, plan 515 (3,808 participants); Cohnreznick Advisory LLC Benefits Program for Retired Partners Under Age 65, plan 520 (2,847 participants)
Broker compensation
$616K across insured contracts
MedicalLife insuranceDentalVisionPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Delta Dental of PennsylvaniaDental5,327$8.9M$268K
Sun Life and Health Insurance CompanyLife, Long-term disability3,574$1.6M$156K
UnitedHealthcare Insurance CompanyVision2,525$892K$48K
Aetna Life Insurance CompanyAccident, Critical Illness, Hospital2,836$573K$87K
Express Scripts, Inc.Prescription drug115$343K$11K
United American Insurance CompanyMedical, HMO115$213K$19K
United of Omaha Life Insurance CompanyLife345$101K$10K
Legalplans, USALegal588$87K$17K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$9.0M/ year

Estimated prescription spend: 3,808 participants × $2,371 national average per member. Usually higher once dependents are counted.

$235K–$579K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$69K–$172K
Lower-cost therapeutic alternatives$100K–$209K
Generic pricing vs. actual cost$43K–$130K
PBM contract terms$23K–$68K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Cohnreznick Advisory LLC
Sponsor EIN
33-3709623
Plan numbers
515, 520
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 33-3709623 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Cohnreznick Advisory LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Cohnreznick Advisory LLC.

Request a correction · Methodology